$18.91
-0.300 (-1.56%)
At Close: Jul 13, 2026
Avalo to Present at Oppenheimer's 32nd Annual Healthcare Conference
07:00am, Tuesday, 08'th Mar 2022
WAYNE, Pa. and ROCKVILLE, Md., March 08, 2022 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a leading clinical-stage precision medicine company that discovers, develops, and commerciali
Do Options Traders Know Something About Avalo (AVTX) Stock We Don't?
09:56am, Wednesday, 17'th Nov 2021
Investors need to pay close attention to Avalo (AVTX) stock based on the movements in the options market lately.
Sign In
Buy AVTX